BE505421A - - Google Patents
Info
- Publication number
- BE505421A BE505421A BE505421DA BE505421A BE 505421 A BE505421 A BE 505421A BE 505421D A BE505421D A BE 505421DA BE 505421 A BE505421 A BE 505421A
- Authority
- BE
- Belgium
- Prior art keywords
- preparation
- carbinol
- compound
- ethinyl
- vehicle
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 92
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims description 82
- -1 ethinyl compound Chemical class 0.000 claims description 69
- 238000002360 preparation method Methods 0.000 claims description 49
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 45
- 238000000034 method Methods 0.000 claims description 40
- 239000003981 vehicle Substances 0.000 claims description 25
- 239000007788 liquid Substances 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 19
- 230000003000 nontoxic Effects 0.000 claims description 17
- 231100000252 nontoxic Toxicity 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 125000004432 carbon atoms Chemical group C* 0.000 claims description 15
- 150000002148 esters Chemical class 0.000 claims description 15
- 239000001257 hydrogen Substances 0.000 claims description 14
- 229910052739 hydrogen Inorganic materials 0.000 claims description 14
- 125000000217 alkyl group Chemical group 0.000 claims description 13
- 239000002775 capsule Substances 0.000 claims description 12
- 239000008157 edible vegetable oil Substances 0.000 claims description 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 10
- 230000002378 acidificating Effects 0.000 claims description 9
- 125000002252 acyl group Chemical group 0.000 claims description 9
- 150000005215 alkyl ethers Chemical class 0.000 claims description 9
- 239000000470 constituent Substances 0.000 claims description 9
- 239000003054 catalyst Substances 0.000 claims description 8
- 239000007903 gelatin capsule Substances 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 125000002950 monocyclic group Chemical group 0.000 claims description 8
- 239000003921 oil Substances 0.000 claims description 8
- 235000019198 oils Nutrition 0.000 claims description 8
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 7
- 125000003367 polycyclic group Chemical group 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 6
- 125000004122 cyclic group Chemical group 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- 238000005984 hydrogenation reaction Methods 0.000 claims description 5
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 5
- 239000000829 suppository Substances 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000001704 evaporation Methods 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 230000001066 destructive Effects 0.000 claims description 3
- 239000000839 emulsion Substances 0.000 claims description 3
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims description 3
- 230000002209 hydrophobic Effects 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 229910052763 palladium Inorganic materials 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 150000002170 ethers Chemical class 0.000 claims description 2
- 230000001256 tonic Effects 0.000 claims description 2
- 230000001131 transforming Effects 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 239000008158 vegetable oil Substances 0.000 claims description 2
- 239000000969 carrier Substances 0.000 claims 14
- 150000001733 carboxylic acid esters Chemical class 0.000 claims 8
- 150000002431 hydrogen Chemical group 0.000 claims 5
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 2
- 210000004940 Nucleus Anatomy 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 claims 1
- 229920000515 polycarbonate Polymers 0.000 claims 1
- 239000004417 polycarbonate Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 229920001098 polystyrene-block-poly(ethylene/propylene) Polymers 0.000 description 111
- 238000009835 boiling Methods 0.000 description 48
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 28
- 230000000147 hypnotic Effects 0.000 description 28
- 239000000243 solution Substances 0.000 description 28
- 230000000694 effects Effects 0.000 description 19
- 235000019441 ethanol Nutrition 0.000 description 18
- 150000002576 ketones Chemical class 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 13
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 12
- 229920000053 polysorbate 80 Polymers 0.000 description 12
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 9
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 8
- 230000002829 reduced Effects 0.000 description 8
- 241000282472 Canis lupus familiaris Species 0.000 description 7
- DDBREPKUVSBGFI-UHFFFAOYSA-N Phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 7
- 229960002695 Phenobarbital Drugs 0.000 description 7
- 230000002921 anti-spasmodic Effects 0.000 description 7
- 239000005977 Ethylene Substances 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 230000000875 corresponding Effects 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- MWWATHDPGQKSAR-UHFFFAOYSA-N Propyne Chemical group CC#C MWWATHDPGQKSAR-UHFFFAOYSA-N 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 239000003326 hypnotic agent Substances 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 230000001766 physiological effect Effects 0.000 description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- 239000011591 potassium Substances 0.000 description 5
- 238000007086 side reaction Methods 0.000 description 5
- 108010010803 Gelatin Proteins 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 239000002250 absorbent Substances 0.000 description 4
- 230000002745 absorbent Effects 0.000 description 4
- IKHGUXGNUITLKF-UHFFFAOYSA-N acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- IJDNQMDRQITEOD-UHFFFAOYSA-N butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 4
- 239000001273 butane Substances 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 230000000881 depressing Effects 0.000 description 4
- VGGSQFUCUMXWEO-UHFFFAOYSA-N ethene Chemical class C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 125000000468 ketone group Chemical group 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 230000002588 toxic Effects 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 241000700198 Cavia Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- SQYNKIJPMDEDEG-UHFFFAOYSA-N Paraldehyde Chemical compound CC1OC(C)OC(C)O1 SQYNKIJPMDEDEG-UHFFFAOYSA-N 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 230000003444 anaesthetic Effects 0.000 description 3
- 150000008064 anhydrides Chemical class 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 231100000053 low toxicity Toxicity 0.000 description 3
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 150000002825 nitriles Chemical class 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 229960003868 paraldehyde Drugs 0.000 description 3
- 230000036961 partial Effects 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000002035 prolonged Effects 0.000 description 3
- 150000003254 radicals Chemical group 0.000 description 3
- 210000002345 respiratory system Anatomy 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- QQZOPKMRPOGIEB-UHFFFAOYSA-N 2-Hexanone Chemical group CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 2
- NUYADIDKTLPDGG-UHFFFAOYSA-N 3,6-dimethyloct-4-yne-3,6-diol Chemical compound CCC(C)(O)C#CC(C)(O)CC NUYADIDKTLPDGG-UHFFFAOYSA-N 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 2
- KRVSOGSZCMJSLX-UHFFFAOYSA-L Chromic acid Chemical compound O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 2
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L Magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 2
- QXLPXWSKPNOQLE-UHFFFAOYSA-N Methylpentynol Chemical compound CCC(C)(O)C#C QXLPXWSKPNOQLE-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M NaHCO3 Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- NZASCBIBXNPDMH-UHFFFAOYSA-N Pyrithyldione Chemical compound CCC1(CC)C(=O)NC=CC1=O NZASCBIBXNPDMH-UHFFFAOYSA-N 0.000 description 2
- 229960005326 Pyrithyldione Drugs 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- ODZPKZBBUMBTMG-UHFFFAOYSA-N Sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 2
- MSXVEPNJUHWQHW-UHFFFAOYSA-N Tert-Amyl alcohol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 2
- WFDIJRYMOXRFFG-UHFFFAOYSA-N acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N acetylene Chemical compound C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 2
- 239000011149 active material Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- YHASWHZGWUONAO-UHFFFAOYSA-N butanoyl butanoate Chemical compound CCCC(=O)OC(=O)CCC YHASWHZGWUONAO-UHFFFAOYSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium monoxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 230000002349 favourable Effects 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000001095 magnesium carbonate Substances 0.000 description 2
- 239000011776 magnesium carbonate Substances 0.000 description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N methylphenylketone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L na2so4 Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 230000002194 synthesizing Effects 0.000 description 2
- 230000001225 therapeutic Effects 0.000 description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 2
- 229910052727 yttrium Inorganic materials 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N 1,1-Diethoxyethane Chemical compound CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- UENOQWSWMYJKIW-UHFFFAOYSA-N 1,2,2-trimethylcyclohexan-1-ol Chemical compound CC1(C)CCCCC1(C)O UENOQWSWMYJKIW-UHFFFAOYSA-N 0.000 description 1
- MFFQMMJYMNKOJT-UHFFFAOYSA-N 1-(1-methylcyclohexyl)propan-1-one Chemical compound CCC(=O)C1(C)CCCCC1 MFFQMMJYMNKOJT-UHFFFAOYSA-N 0.000 description 1
- ONBABKGXIKBWKD-UHFFFAOYSA-N 1-(2,3-dimethylcyclopentyl)ethanone Chemical compound CC1CCC(C(C)=O)C1C ONBABKGXIKBWKD-UHFFFAOYSA-N 0.000 description 1
- YXWWHNCQZBVZPV-UHFFFAOYSA-N 1-(2-methylphenyl)ethanone Chemical compound CC(=O)C1=CC=CC=C1C YXWWHNCQZBVZPV-UHFFFAOYSA-N 0.000 description 1
- PNWJVHYZMCSHNP-UHFFFAOYSA-N 1-(3,3,5-trimethylcyclohexyl)ethanol Chemical compound CC(O)C1CC(C)CC(C)(C)C1 PNWJVHYZMCSHNP-UHFFFAOYSA-N 0.000 description 1
- BUZYGTVTZYSBCU-UHFFFAOYSA-N 1-(4-chlorophenyl)ethanone Chemical compound CC(=O)C1=CC=C(Cl)C=C1 BUZYGTVTZYSBCU-UHFFFAOYSA-N 0.000 description 1
- KDKYADYSIPSCCQ-UHFFFAOYSA-N 1-Butyne Chemical group CCC#C KDKYADYSIPSCCQ-UHFFFAOYSA-N 0.000 description 1
- IBXNCJKFFQIKKY-UHFFFAOYSA-N 1-Pentyne Chemical group CCCC#C IBXNCJKFFQIKKY-UHFFFAOYSA-N 0.000 description 1
- QHTCQBSMFDAJJA-UHFFFAOYSA-N 1-chloro-1,2,2-trimethylcyclohexane Chemical compound CC1(C)CCCCC1(C)Cl QHTCQBSMFDAJJA-UHFFFAOYSA-N 0.000 description 1
- RIFKADJTWUGDOV-UHFFFAOYSA-N 1-cyclohexylethanone Chemical compound CC(=O)C1CCCCC1 RIFKADJTWUGDOV-UHFFFAOYSA-N 0.000 description 1
- NPJUWQOZDGNZBE-UHFFFAOYSA-N 2,2-diethylcyclohexan-1-one Chemical compound CCC1(CC)CCCCC1=O NPJUWQOZDGNZBE-UHFFFAOYSA-N 0.000 description 1
- WYJOVVXUZNRJQY-UHFFFAOYSA-N 2-Acetylthiophene Chemical compound CC(=O)C1=CC=CS1 WYJOVVXUZNRJQY-UHFFFAOYSA-N 0.000 description 1
- XNLICIUVMPYHGG-UHFFFAOYSA-N 2-Pentanone Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 description 1
- NKTDTMONXHODTI-UHFFFAOYSA-N 2-Pentyne Chemical group CCC#CC NKTDTMONXHODTI-UHFFFAOYSA-N 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N 2-isopropyl-5-methylcyclohexanone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- HFBZRMAAZCVYPI-UHFFFAOYSA-N 2-methyl-3,1-benzoxathiin-4-one Chemical compound C1=CC=C2SC(C)OC(=O)C2=C1 HFBZRMAAZCVYPI-UHFFFAOYSA-N 0.000 description 1
- POSWICCRDBKBMH-UHFFFAOYSA-N 3,3,5-trimethylcyclohexan-1-one Chemical compound CC1CC(=O)CC(C)(C)C1 POSWICCRDBKBMH-UHFFFAOYSA-N 0.000 description 1
- DQQNMIPXXNPGCV-UHFFFAOYSA-N 3-Hexyne Chemical group CCC#CCC DQQNMIPXXNPGCV-UHFFFAOYSA-N 0.000 description 1
- FDPIMTJIUBPUKL-UHFFFAOYSA-N 3-Pentanone Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 1
- UJBOOUHRTQVGRU-UHFFFAOYSA-N 3-methylcyclohexan-1-one Chemical compound CC1CCCC(=O)C1 UJBOOUHRTQVGRU-UHFFFAOYSA-N 0.000 description 1
- WSJMICJTINBVDQ-UHFFFAOYSA-N 4-ethylhexane-2,3-dione Chemical compound CCC(CC)C(=O)C(C)=O WSJMICJTINBVDQ-UHFFFAOYSA-N 0.000 description 1
- XADCKKKOYZJNAR-UHFFFAOYSA-N 4-methoxycyclohexan-1-one Chemical compound COC1CCC(=O)CC1 XADCKKKOYZJNAR-UHFFFAOYSA-N 0.000 description 1
- OXRWICUICBZVAE-UHFFFAOYSA-N 4-methylpent-1-yne Chemical group CC(C)CC#C OXRWICUICBZVAE-UHFFFAOYSA-N 0.000 description 1
- SLMFWJQZLPEDDU-UHFFFAOYSA-N 4-methylpent-2-yne Chemical group CC#CC(C)C SLMFWJQZLPEDDU-UHFFFAOYSA-N 0.000 description 1
- 241000220479 Acacia Species 0.000 description 1
- NTPLXRHDUXRPNE-UHFFFAOYSA-N Acetanisole Chemical compound COC1=CC=C(C(C)=O)C=C1 NTPLXRHDUXRPNE-UHFFFAOYSA-N 0.000 description 1
- YRKCREAYFQTBPV-UHFFFAOYSA-N Acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 206010003246 Arthritis Diseases 0.000 description 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N Barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- KVNRLNFWIYMESJ-UHFFFAOYSA-N Butyronitrile Chemical compound CCCC#N KVNRLNFWIYMESJ-UHFFFAOYSA-N 0.000 description 1
- ZXEHQRWEXBCFLB-UHFFFAOYSA-N CC(=O)OC1(CCCC1)C=C Chemical compound CC(=O)OC1(CCCC1)C=C ZXEHQRWEXBCFLB-UHFFFAOYSA-N 0.000 description 1
- 229960003563 Calcium Carbonate Drugs 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N Cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- IYXGSMUGOJNHAZ-UHFFFAOYSA-N Diethyl malonate Chemical compound CCOC(=O)CC(=O)OCC IYXGSMUGOJNHAZ-UHFFFAOYSA-N 0.000 description 1
- 229940064790 Dilantin Drugs 0.000 description 1
- 206010014357 Electric shock Diseases 0.000 description 1
- CXOFVDLJLONNDW-UHFFFAOYSA-N Epinat Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N Ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N Ethyl butyrate Chemical compound CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 238000003747 Grignard reaction Methods 0.000 description 1
- OJVAMHKKJGICOG-UHFFFAOYSA-N Hexane-2,5-dione Chemical compound CC(=O)CCC(C)=O OJVAMHKKJGICOG-UHFFFAOYSA-N 0.000 description 1
- 229940060367 Inert Ingredients Drugs 0.000 description 1
- 210000000936 Intestines Anatomy 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- OZWKMVRBQXNZKK-UHFFFAOYSA-N Ketorolac Chemical compound OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 OZWKMVRBQXNZKK-UHFFFAOYSA-N 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N Methyl iodide Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- SYBYTAAJFKOIEJ-UHFFFAOYSA-N Methyl isopropyl ketone Chemical compound CC(C)C(C)=O SYBYTAAJFKOIEJ-UHFFFAOYSA-N 0.000 description 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N Methyl radical Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 1
- UAEPNZWRGJTJPN-UHFFFAOYSA-N Methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 210000003739 Neck Anatomy 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N Pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 1
- 229960001412 Pentobarbital Drugs 0.000 description 1
- 239000004698 Polyethylene (PE) Substances 0.000 description 1
- FEMRXDWBWXQOGV-UHFFFAOYSA-N Potassium amide Chemical compound [NH2-].[K+] FEMRXDWBWXQOGV-UHFFFAOYSA-N 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N Propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- FVSKHRXBFJPNKK-UHFFFAOYSA-N Propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 1
- 206010038678 Respiratory depression Diseases 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 1
- 241000207961 Sesamum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 229940005550 Sodium alginate Drugs 0.000 description 1
- KIEOKOFEPABQKJ-UHFFFAOYSA-N Sodium dichromate Chemical compound [Na+].[Na+].[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O KIEOKOFEPABQKJ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 210000002784 Stomach Anatomy 0.000 description 1
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 1
- 240000000280 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O Chemical class [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 231100000494 adverse effect Toxicity 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 150000004791 alkyl magnesium halides Chemical class 0.000 description 1
- 230000000202 analgesic Effects 0.000 description 1
- 230000002456 anti-arthritic Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 150000007656 barbituric acids Chemical class 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- XRGPFNGLRSIPSA-UHFFFAOYSA-N butyn-2-one Chemical group CC(=O)C#C XRGPFNGLRSIPSA-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L cacl2 Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 150000001662 cadmium compounds Chemical class 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 231100000160 chronic toxicity Toxicity 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 150000003997 cyclic ketones Chemical class 0.000 description 1
- RGSFGYAAUTVSQA-UHFFFAOYSA-N cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 1
- 230000000593 degrading Effects 0.000 description 1
- 230000002939 deleterious Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- QSJXEFYPDANLFS-UHFFFAOYSA-N diacetyl Chemical group CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 230000001747 exhibiting Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 150000002334 glycols Chemical group 0.000 description 1
- AMSFEMSYKQQCHL-UHFFFAOYSA-N hept-2-yne Chemical group CCCCC#CC AMSFEMSYKQQCHL-UHFFFAOYSA-N 0.000 description 1
- OHMBHFSEKCCCBW-UHFFFAOYSA-N hexane-2,5-diol Chemical compound CC(O)CCC(C)O OHMBHFSEKCCCBW-UHFFFAOYSA-N 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 230000003301 hydrolyzing Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229910001623 magnesium bromide Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- GFTXWCQFWLOXAT-UHFFFAOYSA-M magnesium;cyclohexane;bromide Chemical compound [Mg+2].[Br-].C1CC[CH-]CC1 GFTXWCQFWLOXAT-UHFFFAOYSA-M 0.000 description 1
- FRIJBUGBVQZNTB-UHFFFAOYSA-M magnesium;ethane;bromide Chemical compound [Mg+2].[Br-].[CH2-]C FRIJBUGBVQZNTB-UHFFFAOYSA-M 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L mgso4 Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000001264 neutralization Effects 0.000 description 1
- 125000002560 nitrile group Chemical group 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 231100000404 nontoxic agent Toxicity 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 150000002901 organomagnesium compounds Chemical class 0.000 description 1
- 210000000056 organs Anatomy 0.000 description 1
- 239000010461 other edible oil Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229930006904 p-menthan-3-one Natural products 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- GTCCGKPBSJZVRZ-UHFFFAOYSA-N pentane-2,4-diol Chemical compound CC(O)CC(C)O GTCCGKPBSJZVRZ-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 150000007519 polyprotic acids Polymers 0.000 description 1
- 230000002335 preservative Effects 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011158 quantitative evaluation Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 239000012260 resinous material Substances 0.000 description 1
- 230000035812 respiration Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 231100000486 side effect Toxicity 0.000 description 1
- MSXHSNHNTORCAW-UHFFFAOYSA-M sodium 3,4,5,6-tetrahydroxyoxane-2-carboxylate Chemical compound [Na+].OC1OC(C([O-])=O)C(O)C(O)C1O MSXHSNHNTORCAW-UHFFFAOYSA-M 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000003890 succinate salts Chemical class 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 231100000048 toxicity data Toxicity 0.000 description 1
- 125000004417 unsaturated alkyl group Chemical group 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
- C07C29/38—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
- C07C29/42—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing triple carbon-to-carbon bonds, e.g. with metal-alkynes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE505421A true BE505421A (de) |
Family
ID=145971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE505421D BE505421A (de) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE505421A (de) |
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2791603A (en) * | 1954-09-23 | 1957-05-07 | Pfizer & Co C | Process for preparing carbamates of tertiary acetylenic carbinols |
| US2791602A (en) * | 1954-04-29 | 1957-05-07 | Pfizer & Co C | Hypnotic agent and intermediate |
| DE1015795B (de) * | 1953-05-12 | 1957-09-19 | Abbott Lab | Verfahren zur Herstellung von AEthinylcarbinolen |
| DE1021843B (de) * | 1953-09-14 | 1958-01-02 | Rheinpreussen Ag | Verfahren zur Herstellung des Allophanats des 1-AEthinylcyclohexanols-(1) |
| DE1028567B (de) * | 1957-03-20 | 1958-04-24 | Knoll Ag | Verfahren zur Herstellung von Bicyclo-(2, 2, 1)-aethinyl-(2)-heptanol-(2) |
| US2865967A (en) * | 1958-12-23 | Process of preparation | ||
| US2882287A (en) * | 1954-08-30 | 1959-04-14 | Air Reduction | Methylbutynyl stearate |
| US2885278A (en) * | 1955-11-17 | 1959-05-05 | Hercules Powder Co Ltd | Herbicidal compositions containing esters of 1-ethynylcyclohexanol |
| DE1058498B (de) * | 1955-03-02 | 1959-06-04 | Hoffmann La Roche | Verfahren zur Herstellung von Methyl-vinyl-[4-methylhexen-(3)-yl-(1)]-carbinylesternmit besonderen Riechstoffeigenschaften |
| US2909461A (en) * | 1958-12-22 | 1959-10-20 | Allied Lab Inc | Process for combating trichuris infection of domestic animals |
| DE1078113B (de) * | 1954-05-11 | 1960-03-24 | Hoffmann La Roche | Verfahren zur Herstellung von durch besondere Riechstoff- eigenschaften ausgezeichneten Estern |
| DE1078111B (de) * | 1954-05-11 | 1960-03-24 | Hoffmann La Roche | Verfahren zur Herstellung von durch besondere Riechstoff-eigenschaften ausgezeichneten Estern |
| DE1080097B (de) * | 1956-11-30 | 1960-04-21 | Hoffmann La Roche | Verfahren zur Herstellung von neuen ungesaettigten tertiaeren Carbinylestern mit besonderen Riechstoffeigenschaften |
| DE1080099B (de) * | 1956-11-30 | 1960-04-21 | Hoffmann La Roche | Verfahren zur Herstellung von neuen ungesaettigten tertiaeren Carbinylestern mit besonderen Riechstoffeigenschaften |
| US2959553A (en) * | 1954-12-09 | 1960-11-08 | Air Reduction | Lubricating oils containing esters of acetylenic alcohols |
| DE1096346B (de) * | 1957-01-08 | 1961-01-05 | Geigy Ag J R | Verfahren zur Herstellung von bis-tertiaeren Glykolen |
| US2993865A (en) * | 1956-08-02 | 1961-07-25 | Dow Chemical Co | Corrosion inhibitors for aluminum |
| US2993862A (en) * | 1956-08-02 | 1961-07-25 | Dow Chemical Co | Acetylenic glycols as corrosion inhibitors |
| US2993864A (en) * | 1956-08-02 | 1961-07-25 | Dow Chemical Co | Ethynylcyclohexyl compounds as corrosion inhibitors |
| US2993863A (en) * | 1956-08-02 | 1961-07-25 | Dow Chemical Co | Halogenated propargyl alcohols as corrosion inhibitors |
| US4151360A (en) * | 1975-01-27 | 1979-04-24 | Hoffmann-La Roche Inc. | Optically active amine salts |
-
0
- BE BE505421D patent/BE505421A/fr unknown
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2865967A (en) * | 1958-12-23 | Process of preparation | ||
| DE1015795B (de) * | 1953-05-12 | 1957-09-19 | Abbott Lab | Verfahren zur Herstellung von AEthinylcarbinolen |
| DE1021843B (de) * | 1953-09-14 | 1958-01-02 | Rheinpreussen Ag | Verfahren zur Herstellung des Allophanats des 1-AEthinylcyclohexanols-(1) |
| US2791602A (en) * | 1954-04-29 | 1957-05-07 | Pfizer & Co C | Hypnotic agent and intermediate |
| DE1078113B (de) * | 1954-05-11 | 1960-03-24 | Hoffmann La Roche | Verfahren zur Herstellung von durch besondere Riechstoff- eigenschaften ausgezeichneten Estern |
| DE1078111B (de) * | 1954-05-11 | 1960-03-24 | Hoffmann La Roche | Verfahren zur Herstellung von durch besondere Riechstoff-eigenschaften ausgezeichneten Estern |
| US2882287A (en) * | 1954-08-30 | 1959-04-14 | Air Reduction | Methylbutynyl stearate |
| US2791603A (en) * | 1954-09-23 | 1957-05-07 | Pfizer & Co C | Process for preparing carbamates of tertiary acetylenic carbinols |
| US2959553A (en) * | 1954-12-09 | 1960-11-08 | Air Reduction | Lubricating oils containing esters of acetylenic alcohols |
| DE1058498B (de) * | 1955-03-02 | 1959-06-04 | Hoffmann La Roche | Verfahren zur Herstellung von Methyl-vinyl-[4-methylhexen-(3)-yl-(1)]-carbinylesternmit besonderen Riechstoffeigenschaften |
| US2885278A (en) * | 1955-11-17 | 1959-05-05 | Hercules Powder Co Ltd | Herbicidal compositions containing esters of 1-ethynylcyclohexanol |
| US2993865A (en) * | 1956-08-02 | 1961-07-25 | Dow Chemical Co | Corrosion inhibitors for aluminum |
| US2993863A (en) * | 1956-08-02 | 1961-07-25 | Dow Chemical Co | Halogenated propargyl alcohols as corrosion inhibitors |
| US2993864A (en) * | 1956-08-02 | 1961-07-25 | Dow Chemical Co | Ethynylcyclohexyl compounds as corrosion inhibitors |
| US2993862A (en) * | 1956-08-02 | 1961-07-25 | Dow Chemical Co | Acetylenic glycols as corrosion inhibitors |
| DE1080099B (de) * | 1956-11-30 | 1960-04-21 | Hoffmann La Roche | Verfahren zur Herstellung von neuen ungesaettigten tertiaeren Carbinylestern mit besonderen Riechstoffeigenschaften |
| DE1080097B (de) * | 1956-11-30 | 1960-04-21 | Hoffmann La Roche | Verfahren zur Herstellung von neuen ungesaettigten tertiaeren Carbinylestern mit besonderen Riechstoffeigenschaften |
| DE1096346B (de) * | 1957-01-08 | 1961-01-05 | Geigy Ag J R | Verfahren zur Herstellung von bis-tertiaeren Glykolen |
| DE1028567B (de) * | 1957-03-20 | 1958-04-24 | Knoll Ag | Verfahren zur Herstellung von Bicyclo-(2, 2, 1)-aethinyl-(2)-heptanol-(2) |
| US2909461A (en) * | 1958-12-22 | 1959-10-20 | Allied Lab Inc | Process for combating trichuris infection of domestic animals |
| US4151360A (en) * | 1975-01-27 | 1979-04-24 | Hoffmann-La Roche Inc. | Optically active amine salts |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE505421A (de) | ||
| EP0018342B1 (de) | Neue Glyzerinverbindungen, ihre Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| FR2532844A1 (fr) | Composition pharmaceutique contenant un compose polyprenylique | |
| BE1004995A3 (fr) | Nouveau derive de 5h-benzodiazepine, compositions pharmaceutiques le contenant et procede pour les preparer. | |
| EP0089894B1 (de) | N-(2-(4-Hydroxy-3-methoxy-phenyl)-2-Hydroxy-Ethyl)3-Amino-1-(1-Benzimidazolyl)-Butan und Salze und Hydrate mit Beta-adrenergischer Aktivität, therapeutische Anwendungen und Verfahren zu deren Herstellung | |
| FR2509725A1 (fr) | (hydroxyalkyl)phenylsulfures, leurs procedes de preparation et compositions pharmaceutiques les contenant | |
| CH646682A5 (fr) | Acide tetramethyl-hexadecapentaenoique, procedes pour sa preparation et composition pharmaceutique contenant cet acide. | |
| CH621325A5 (de) | ||
| EP0060776B1 (de) | Arzneimittel für die Behandlung der Fettleibigkeit und der Hyperlipämie | |
| EP0002408A1 (de) | Substituierte Phenoxyalkanole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| FR2518537A1 (fr) | Nouveaux derives de l'acide phenylacetique, leur preparation et compositions les contenant | |
| FR2477874A1 (fr) | Composition de parfum a base de tricyclo (5.2.1.0.2,6) decane-2-carboxylate de methyle et son procede de preparation | |
| EP0056500A2 (de) | Ester der 2,2,-Dimethyl-Propionsäure, ihre Verwendung als Riechstoffe und eine sie enthaltende Zusammensetzung | |
| FR3144618A1 (fr) | Procédé de préparation de composés dérivés de 4-(3-éthoxy-4-hydroxyphényl)butan-2-one | |
| BE665158A (de) | ||
| BE532743A (de) | ||
| BE512433A (de) | ||
| CH629796A5 (en) | Therapeutically active compounds of 4-(2-thienylmethylamino)benzoic acid | |
| BE519278A (de) | ||
| BE690516A (de) | ||
| BE542278A (de) | ||
| BE635615A (de) | ||
| CH600799A5 (en) | Aromatising flavourings for tobacco, food, drink etc. | |
| BE540075A (de) | ||
| BE533490A (de) |